Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reissue Patent
2005-07-19
2005-07-19
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S231800, C514S232200, C514S235500, C514S239500, C514S354000, C514S355000, C514S448000, C514S415000, C514S617000, C514S619000, C514S620000, C514S621000, C514S625000, C514S626000, C514S629000, C514S599000, C514S657000, C514S414000, C514S418000, C514S764000, C514S751000
Reissue Patent
active
RE038761
ABSTRACT:
A method of inhibiting cell proliferation in a patient suffering from such disorder comprising administering to said patient an effective amount of a composition comprising, in admixture with a pharmaceutically acceptable carrier, a compound, or a pharmaceutically acceptable salt thereof, which is a substituted styrene compound which can also be a naphthalene, an indane or a benzoxazine; including nitrile and molononitrile compounds, and pharmaceutical compositions comprising, in admixture with a pharmaceutically acceptable carrier, a pharmaceutically-effective amount of such compound.
REFERENCES:
patent: 3149148 (1964-09-01), Kladko et al.
patent: 3527785 (1970-09-01), Ozaki et al.
patent: 4064266 (1977-12-01), Birchall et al.
patent: 0 339 671 (1989-11-01), None
patent: 0 403 238 (1990-12-01), None
patent: SHO 62-39558 (1987-02-01), None
patent: 148038 (1969-06-01), None
Chemical Abstracts, vol. 111, abstract No. 187005f, 1989.
Shiraishi et al,Chemical Abstracts, vol. 106, No. 24, abstract No. 201758; 1987, p. 356.
Chem. Abst. 111-187005f (1989).
P. Yaish, A. Gazit, C. Gilon and A. Levitzki,Science, 242, pp. 933-935 (Nov. 11, 1988).
A. Gazit, P. Yaish, C. Gilon and A. Levitzki,J. Med. Chem.32, pp. 2344-2352 (Oct., 1989).
T. Shiraishi, K. Kameyama, N. Imai, T. Domoto, I. Katsumi and K. Watanabe,Chem. Pharm. Bull., 36(3) pp. 974-981 (1988).
T. Shiraishi, T. Domota, N. Imai, Y. Shimada and K. Watanabe,Biochemical and Biophysical Research Communications, 147(1), pp. 322-328 (Aug. 31, 1987).
E.M. Gal, F. Fung and D.M. Greenberg,Cancer Research, vol. 12, pp. 565-572 (1952).
I. Katsumi,Chem. Pharm. Bull., vol. 34(1), pp. 1619-1627.
E. Gal, F. Fung and D. Greenberg,Cancer Research, vol. 12, pp. 574-579 (1952).
Chorev Michael
Gazit Aviv
Gilon Chaim
Levitzki Alexander
Cook Rebecca
Winston & Strawn LLP
Yissum Research Development Company of the Hebrew University of
LandOfFree
Styryl compounds which inhibit EGF receptor protein tyrosine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Styryl compounds which inhibit EGF receptor protein tyrosine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Styryl compounds which inhibit EGF receptor protein tyrosine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3426055